Bleeding risk |
Surgery/procedure |
Clinical implications |
Minimal |
– Cataract surgery – Dermatologic procedures (eg, biopsy) – Gastroscopy or colonoscopy without biopsies – Permanent pacemaker insertion or internal defibrillator placement (if bridging anticoagulation is not used) – Selected procedures with small-bore needles (eg, thoracentesis, paracentesis, arthrocentesis) – Dental extractions (≤2 teeth) – Endodontic (root canal) procedure – Subgingival scaling or other cleaning |
Continue VKAs and DOACs without interruptiona |
Low/moderate |
– Abdominal surgery (eg, cholecystectomy, hernia repair, colon resection) – Other general surgery (eg, breast surgery) – Other intrathoracic surgery – Other orthopedic surgery – Other vascular surgery – Noncataract ophthalmologic surgery – Gastroscopy or colonoscopy with biopsies – Coronary angiographyb – Selected procedures with large-bore needles (eg, bone marrow biopsy, lymph node biopsy) – Complex dental procedure (eg, multiple tooth extractions) |
– Interrupt VKAs for 5 days – Interrupt DOACs for 1 day before and 1 day after surgery/procedure |
High |
– Any surgery or procedure with neuraxial (spinal or epidural) anesthesia – Neurosurgery (intracranial or spinal) – Cardiac surgery (eg, CABG, heart valve replacement) – Major vascular surgery (eg, aortic aneurysm repair, aortofemoral bypass) – Major orthopedic surgery (eg, hip/knee joint replacement surgery) – Lung resection surgery – Urologic surgery (eg, prostatectomy, bladder tumor resection) – Extensive cancer surgery (involving, eg, pancreas, liver) – Intestinal anastomosis surgery – Reconstructive plastic surgery – Selected procedures involving vascular organs (eg, kidney biopsy, prostate biopsy) or high bleeding risk interventions (eg, colonic polypectomy, endoscopic sphincterotomy, spinal injection, pericardiocentesis) |
– Interrupt VKAs for 5 days – Interrupt DOACs for 2 days before and 2 days after surgery/procedure |
a There may be selected patients in whom VKA or DOAC interruption is warranted. b The radial approach may be considered as carrying minimal bleeding risk compared with the femoral approach. | ||
CABG, coronary artery bypass graft; DOAC, direct oral anticoagulant; VKA, vitamin K antagonist. |